SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-209186
Filing Date
2008-10-10
Accepted
2008-10-10 17:16:07
Documents
3
Period of Report
2008-10-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15619
2 PRESS RELEASE ISSUED BY THE REGISTRANT ON OCTOBER 10, 2008 dex991.htm EX-99.1 8061
3 GRAPHIC g66262g88d43.jpg GRAPHIC 1904
  Complete submission text file 0001193125-08-209186.txt   28039
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 081119040
SIC: 2834 Pharmaceutical Preparations